Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Responsiveness in Pediatric Migraine
NCT07180043Completed
- Sponsor
- Kayseri University
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of propranolol in migraine (2 arms), sponsored by Kayseri University. Primary endpoints: Pediatric Migraine Disability Assessment at 12 weeks and Visual Analog Scale at 12 weeks. Started Jan 2021; status: completed.
02
Drugs
propranolol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07180043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180043.